These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 18973917)

  • 1. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
    Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
    Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
    [No Abstract]   [Full Text] [Related]  

  • 3. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
    Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic determinants in epithelioid sarcoma.
    Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
    Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INI1-deficient tumors: diagnostic features and molecular genetics.
    Hollmann TJ; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B; Jambhekar NA
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
    Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
    Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
    Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
    Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
    Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
    Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
    Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
    Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
    Al-Hussaini M; Hirschowitz L; McCluggage WG
    Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.